---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-083385"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:46:21.274899+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Renalytix repays $1.06M of convertible bond with shares and ADSs

## Summary
- Issued 2.275M ordinary shares and 4.641M ADSs to settle $1.06M principal and interest due July 7, 2024.
- Remaining convertible bond principal reduced to $11.66M from $12.72M.
- Shares issued under Section 3(a)(9) exemption; no registration.
- 11.56M new ordinary shares to be admitted to AIM on July 17, 2024.
- Post-Admission total ordinary shares: 165,925,513; each ADS represents two ordinary shares.

## SEC filing metadata
- accession: 0000950170-24-083385
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024083385/0000950170-24-083385-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024083385/rnlx-20240715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-083385
- JSON: https://secwatch.observer/filing/0000950170-24-083385.json
- Plain text: https://secwatch.observer/filing/0000950170-24-083385.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.